All
RSSArticles
-
Ulipristal Acetate Extends the Emergency Contraception Window
In this open-label study, women ages 18 years or older with regular cycles who presented for emergency contraception 48-120 hours after unprotected intercourse at 45 Planned Parenthood clinics throughout the United States were treated with a single oral dose of 30 mg ulipristal acetate. -
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Thiazolidinediones and Risk of Heart Failure
In this issue: FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions. -
Can We Accurately Predict Fluid Responsiveness?
Passive leg raising (PLR), a rapidly reversible maneuver that simulates rapid volume expansion by putting several hundred milliliters of fluid back into the circulation, has been shown to predict fluid responsiveness in mechanically ventilated patients. -
Critical Care Alert April 2010 Issue in PDF
-
Special Feature: Evidence Is Not Enough: Knowledge Translation in the ICU
With increased emphasis on evidence-based medicine during the last dozen years has come the implicit assumption that the availability of more and better evidence on how disease should be diagnosed and managed will lead to better patient care. -
Use research to minimize bone loss in DMPA users
Findings from a new study identify women at higher risk of significant bone loss on injectable birth control. -
New data on abstinence — What do they mean for teen pregnancy prevention?
Results from new research of a theory-based, abstinence-only intervention appear to be associated with a lower rate of sexual involvement among African American sixth- and seventh-graders. -
Healthcare Risk Management - Full March 2010 Issue in PDF
-
LR&C: Alleged failure to diagnose, monitor: Case settled
A woman presented at two hospital emergency departments (ED) complaining of a number of respiratory symptoms. She was not admitted and was sent home with a prescription.